SCHEMBL7974236

SCHEMBL7974236

CC(C)(C)c1ccc(Cn2cnc3nc(-c4cccnc4)[nH]c(=O)c32)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.43
KCNJ11 Q14654 1/20 0.43
HPGD P15428 2/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KMT2A Q03164 2/20 0.41
KIF11 P52732 1/20 0.41
PNP P00491 1/20 0.40
MAPT P10636 3/20 0.40
KDM4C Q9H3R0 1/20 0.40
CNOT7 Q9UIV1 1/20 0.39
DHPS P49366 1/20 0.37
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
TP53 P04637 1/20 0.37
CLK1 P49759 1/20 0.37
DYRK1A Q13627 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984766 0.89 HPGD (0.44) HPGDALDH1A1SMN1; SMN2KMT2APNP
SCHEMBL7974486 0.89 SMN1; SMN2 (0.50) ABCC8KCNJ11HPGDALDH1A1SMN1; SMN2
SCHEMBL7984930 0.88 ABCC8 (0.47) ABCC8KCNJ11HPGDALDH1A1SMN1; SMN2
SCHEMBL7974283 0.88 ALDH1A1 (0.53) HPGDALDH1A1SMN1; SMN2KMT2APNP
SCHEMBL7989418 0.87 SMN1; SMN2 (0.44) HPGDALDH1A1SMN1; SMN2KMT2APNP
SCHEMBL7991397 0.84 ABCC8 (0.43) ABCC8KCNJ11HPGDALDH1A1SMN1; SMN2
SCHEMBL7985008 0.84 ABCC8 (0.43) ABCC8KCNJ11HPGDALDH1A1SMN1; SMN2
SCHEMBL7974239 0.84 CNOT7 (0.45) ABCC8KCNJ11ALDH1A1KMT2AKIF11
SCHEMBL7988517 0.84 ABCC8 (0.47) ABCC8KCNJ11HPGDALDH1A1SMN1; SMN2
SCHEMBL7974275 0.83 HPGD (0.43) ABCC8KCNJ11HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed